Cargando…
Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
Our article Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review had instigated a critique that there were more cases of post-COVID-19-vaccination NMOSD. Indeed, after the systematic review was performed in July 2021, many reports have been...
Autores principales: | Tisavipat, Nanthaya, Anamnart, Chumpol, Owattanapanich, Weerapat, Apiwattanakul, Metha, Savangned, Pakawee, Prayoonwiwat, Naraporn, Siritho, Sasitorn, Rattanathamsakul, Natthapon, Jitprapaikulsan, Jiraporn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273309/ https://www.ncbi.nlm.nih.gov/pubmed/35843141 http://dx.doi.org/10.1016/j.msard.2022.104055 |
Ejemplares similares
-
Effect of plasma exchange in neuromyelitis optica spectrum disorder: A systematic review and meta‐analysis
por: Kosiyakul, Punchika, et al.
Publicado: (2020) -
Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis
por: Songwisit, Sakdipat, et al.
Publicado: (2020) -
Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis
por: Srikajon, Jindapa, et al.
Publicado: (2018) -
Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2020) -
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
por: Hyun, Jae-Won, et al.
Publicado: (2022)